Upgrade to SI Premium - Free Trial

Recursion Pharmaceuticals (RXRX)

3.80 +0.33 (9.51%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/11/26)

Latest Headlines

Form 4 RECURSION PHARMACEUTICAL For: Jun 02 Filed by: Borgeson Blake June 4, 2026 5:05 PM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: Jun 03 Filed by: Bumpus Namandje June 4, 2026 5:05 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Bumpus Namandje June 3, 2026 10:16 AM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Borgeson Blake June 2, 2026 11:05 AM - SEC Filing Recursion to Participate in Upcoming Investor Conferences June 2, 2026 8:00 AM - StreetInsider Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules May 29, 2026 4:30 PM - StreetInsider Form 4 RECURSION PHARMACEUTICAL For: May 22 Filed by: Gibson Christopher May 27, 2026 4:15 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher May 22, 2026 10:14 AM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: May 15 Filed by: Khan Najat May 19, 2026 5:55 PM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: May 15 Filed by: Hallett David May 19, 2026 5:55 PM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: May 15 Filed by: Gibson Christopher May 19, 2026 5:55 PM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: May 15 Filed by: Taylor Ben R May 19, 2026 5:55 PM - SEC Filing Altitude Lab Portfolio Companies Surpass $205 Million in Funding, Marking a New Era for Early-Stage Biotechs in Salt Lake City May 19, 2026 12:07 PM - Globe NewsWire Recursion Pharmaceuticals (RXRX) PT Raised to $5.50 at Morgan Stanley May 14, 2026 8:53 AM - StreetInsider Form SCHEDULE 13G RECURSION PHARMACEUTICAL Filed by: STATE STREET CORP May 12, 2026 11:53 AM - SEC Filing The Future of Intoxication Detection May Be in Your Voice May 11, 2026 8:30 AM - Globe NewsWire Form 4 RECURSION PHARMACEUTICAL For: May 07 Filed by: Gibson Christopher May 8, 2026 4:59 PM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: May 05 Filed by: Borgeson Blake May 7, 2026 4:45 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher May 7, 2026 11:14 AM - SEC Filing Recursion Pharmaceuticals, Inc. (RXRX) Tops Q1 EPS by 4c, offers outlook May 6, 2026 6:34 AM - StreetInsider Form 10-Q RECURSION PHARMACEUTICAL For: Mar 31 May 6, 2026 6:33 AM - SEC Filing Form 8-K RECURSION PHARMACEUTICAL For: May 06 May 6, 2026 6:32 AM - SEC Filing Recursion Reports First Quarter Financial Results and Provides Business Update May 6, 2026 6:30 AM - Globe NewsWire Form 144 RECURSION PHARMACEUTICAL Filed by: Borgeson Blake May 5, 2026 10:22 AM - SEC Filing Form ARS RECURSION PHARMACEUTICAL For: Dec 31 April 30, 2026 4:38 PM - SEC Filing Form DEFA14A RECURSION PHARMACEUTICAL April 30, 2026 4:37 PM - SEC Filing Form DEF 14A RECURSION PHARMACEUTICAL For: Apr 30 April 30, 2026 4:36 PM - SEC Filing Form 8-K RECURSION PHARMACEUTICAL For: Apr 28 April 30, 2026 4:33 PM - SEC Filing Recursion Announces Board Transition April 30, 2026 4:30 PM - StreetInsider Recursion Pharmaceuticals (RXRX) PT Lowered to $10 at JPMorgan April 30, 2026 9:26 AM - StreetInsider Recursion to Report First Quarter 2026 Business Updates and Financial Results on May 6 April 29, 2026 7:59 AM - Globe NewsWire Form 4 RECURSION PHARMACEUTICAL For: Apr 22 Filed by: Gibson Christopher April 24, 2026 4:23 PM - SEC Filing Form SCHEDULE 13G/A RECURSION PHARMACEUTICAL Filed by: BlackRock, Inc. April 24, 2026 4:13 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher April 22, 2026 9:47 AM - SEC Filing Recursion CEO outlines AI drug discovery strategy in Morgan Stanley webcast April 15, 2026 3:34 PM - StreetInsider Form 4 RECURSION PHARMACEUTICAL For: Apr 06 Filed by: Taylor Ben R April 8, 2026 4:59 PM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: Apr 07 Filed by: Gibson Christopher April 8, 2026 4:59 PM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: Apr 07 Filed by: Borgeson Blake April 8, 2026 4:58 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher April 7, 2026 1:14 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Borgeson Blake April 7, 2026 1:08 PM - SEC Filing Recursion to Participate in Upcoming Investor Conferences April 7, 2026 12:31 PM - Globe NewsWire Recursion to Participate in Upcoming Investor Conferences April 7, 2026 8:14 AM - StreetInsider Form 4 RECURSION PHARMACEUTICAL For: Apr 01 Filed by: Dar Zavain April 2, 2026 4:56 PM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: Apr 01 Filed by: Li Dean Y April 2, 2026 4:56 PM - SEC Filing Recursion expands Citeline partnership to enhance AI drug platform March 31, 2026 9:00 AM - StreetInsider Recursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech Platform March 31, 2026 9:00 AM - StreetInsider Form SCHEDULE 13G/A RECURSION PHARMACEUTICAL Filed by: VANGUARD GROUP INC March 27, 2026 11:36 AM - SEC Filing Form 8-K RECURSION PHARMACEUTICAL For: Mar 25 March 25, 2026 4:43 PM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: Mar 23 Filed by: Gibson Christopher March 25, 2026 4:37 PM - SEC Filing Recursion names Vicki Goodman as chief medical officer March 25, 2026 7:59 AM - StreetInsider Recursion Announces Vicki Goodman, M.D., as Incoming Chief Medical Officer March 25, 2026 7:59 AM - StreetInsider Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher March 23, 2026 10:50 AM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: Mar 16 Filed by: Taylor Ben R March 18, 2026 5:53 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Taylor Ben R March 17, 2026 10:53 AM - SEC Filing Nvidia’s Bet on Digital Biology and Stocks That Could Ride the Wave March 16, 2026 10:00 AM - StreetInsider Form 4 RECURSION PHARMACEUTICAL For: Mar 09 Filed by: Gibson Christopher March 11, 2026 5:41 PM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: Mar 09 Filed by: Khan Najat March 11, 2026 5:41 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Khan Najat March 9, 2026 1:46 PM - SEC Filing Full Article List